Author: apopescu@pmlive.com

Immune checkpoint inhibitors – why they matter in today’s cancer research

Cancer research hinges on developing improved methods to effectively lyse cancer cells. This is where immune checkpoint inhibitors come into direct focus

Do we really know our customers?

Why patient centricity throughout the lifecycle is not a fad, sales tactic or trend

Unlocking potential: How can pharma capitalise on its resources to support the NHS?

Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online

Tackling pharma’s predatory research problem

Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences

Working together: the 3rd Annual Patient Engagement and Experience Conference

The importance of a patient-centric focus to improve the real-world use of medicine was extensively discussed during the 3^rd Annual Patient Engagement and Experience Conference (16–17th May 2018, Amsterdam, Netherlands).